Pump Supplies denied as non-formulary by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for pump supplies are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Issues a Non-Formulary Denial for Pump Supplies

Blue Cross Blue Shield's non-formulary denials for insulin pump supplies typically arise when the specific supply brand, model, or system — for example, a particular infusion set, reservoir, or integrated continuous glucose monitoring (CGM) component — is not on BCBS's preferred DME or formulary list for the benefit year. BCBS may have a contracted preferred supplier or preferred device line, and supplies from a non-preferred manufacturer or system may require additional justification or be subject to a higher cost-share.

This type of denial is distinct from a medical-necessity denial: BCBS is not questioning whether pump therapy is appropriate, but rather whether the specific supply item you were dispensed is the preferred product. Appeals succeed when the clinical record documents why the non-preferred supply is medically necessary over the formulary alternative — or when no therapeutically equivalent formulary alternative exists for your pump system.

## Your Federal Appeal Rights

• Internal appeal: Under ACA §2719 and ERISA §503, you have the right to a full internal review. BCBS must identify the specific non-formulary classification, name the preferred formulary alternative (if one exists), and explain the exception criteria.
• External review: Independent external review is available after internal exhaustion, typically within approximately four months of final internal denial.
• Expedited track: Available for urgent supply situations, including active pump therapy where substitution is not immediately feasible.

## Documentation to Gather

1. Current pump model documentation — confirm the make and model of the insulin pump in use. Many supply systems are proprietary and not interchangeable across manufacturers. 2. Prescriber letter — your physician should document why the prescribed supply is medically necessary and — critically — whether a formulary alternative is compatible with your specific pump model. If supplies are not interchangeable, this is a strong non-formulary exception argument. 3. Adverse reaction or failure history — if a formulary alternative was previously tried and caused an adverse outcome (e.g., skin reactions, occlusions, delivery failures), document this with dates and clinical notes. 4. ADA/AACE guideline reference — if applicable, your physician may reference professional-society guidance on individualized diabetes device selection.

## Criteria-Mapping Structure

Request BCBS's written exception criteria for non-formulary DME supplies:

| BCBS Non-Formulary Exception Criterion | Your Evidence | |---|---| | Formulary alternative is not clinically equivalent | [Pump model incompatibility documentation or adverse history] | | [Additional exception criteria] | [Chart note, date, prescriber] |

## Next Step

Before filing a formal appeal, confirm with BCBS whether the denial can be resolved through a formulary exception request — which is often a simpler and faster process than a full internal appeal. If a formulary alternative genuinely does not exist for your pump system, that fact alone is typically sufficient to grant an exception.